BRIEF-Chelsea Therapeutics down 27.8 percent premarket

NEW YORK Fri Jan 10, 2014 9:02am EST

NEW YORK Jan 10 (Reuters) - Chelsea Therapeutics International Ltd : * Down 27.8 percent to $2.55 in premarket after FDA staff comments on droxidopa drug

FILED UNDER: